Advancing Treatment of Bladder Cancer
CME Monograph - July 2008
This activity was intended for oncologists, urologists and other medical professionals who assess, treat and counsel patients with bladder cancer.
Faculty
Colin P. N. Dinney, MD
The University of Texas M. D. Anderson Cancer Center
Maha Hussain, MD, FACP
University of Michigan Comprehensive Cancer Center.
A link to the online monograph is below.
The activity is no longer valid.
Educational Need
Physicians who manage and counsel patients with bladder cancer need to assess and integrate into their practice of treatment and patient counseling: (a) the current framework for assessing appropriate use of systemic chemotherapy for muscle-invasive disease and (b) optimal approaches to treating superficial bladder, particularly for BCG-resistant disease.
Educational Grant Support
Supported by educational grants provided by Bristol-Myers Squibb Company, Eli Lilly and Company and Schering Corporation.
Sponsorship
CME sponsorship was provided by InforMEDical Communications, Inc.
